These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25429872)

  • 1. Doctors trial amiodarone for Ebola in Sierra Leone.
    Turone F
    BMJ; 2014 Nov; 349():g7198. PubMed ID: 25429872
    [No Abstract]   [Full Text] [Related]  

  • 2. Concerns about the off-licence use of amiodarone for Ebola.
    Gupta-Wright A; Lavers J; Irvine S
    BMJ; 2015 Jan; 350():h272. PubMed ID: 25647614
    [No Abstract]   [Full Text] [Related]  

  • 3. Ebola seen up-close.
    Satolli R
    Eur J Intern Med; 2015 Mar; 26(2):80-1. PubMed ID: 25682443
    [No Abstract]   [Full Text] [Related]  

  • 4. Small molecule inhibitors of ebola virus infection.
    Picazo E; Giordanetto F
    Drug Discov Today; 2015 Feb; 20(2):277-86. PubMed ID: 25532798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of therapeutics for treatment of Ebola virus infection.
    Li H; Ying T; Yu F; Lu L; Jiang S
    Microbes Infect; 2015 Feb; 17(2):109-17. PubMed ID: 25498866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ebola and ethics.
    Griffiths PD
    Rev Med Virol; 2014 Nov; 24(6):363-4. PubMed ID: 25318448
    [No Abstract]   [Full Text] [Related]  

  • 7. Amiodarone and metabolite MDEA inhibit Ebola virus infection by interfering with the viral entry process.
    Salata C; Baritussio A; Munegato D; Calistri A; Ha HR; Bigler L; Fabris F; Parolin C; Palù G; Mirazimi A
    Pathog Dis; 2015 Jul; 73(5):. PubMed ID: 25933611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amiodarone affects Ebola virus binding and entry into target cells.
    Salata C; Munegato D; Martelli F; Parolin C; Calistri A; Baritussio A; Palù G
    New Microbiol; 2018 Apr; 41(2):162-164. PubMed ID: 29498743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Vitro and In Vivo Activity of Amiodarone Against Ebola Virus.
    Dyall J; Johnson JC; Hart BJ; Postnikova E; Cong Y; Zhou H; Gerhardt DM; Michelotti J; Honko AN; Kern S; DeWald LE; O'Loughlin KG; Green CE; Mirsalis JC; Bennett RS; Olinger GG; Jahrling PB; Hensley LE
    J Infect Dis; 2018 Nov; 218(suppl_5):S592-S596. PubMed ID: 30016444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Editorial Commentary: Considerations of Favipiravir as a Medical Countermeasure in Future Randomized Controlled Trials Against Ebola Virus Disease.
    Kraft CS
    Clin Infect Dis; 2016 Nov; 63(10):1295-1296. PubMed ID: 27553374
    [No Abstract]   [Full Text] [Related]  

  • 11. Measuring the impact of Ebola control measures in Sierra Leone.
    Kucharski AJ; Camacho A; Flasche S; Glover RE; Edmunds WJ; Funk S
    Proc Natl Acad Sci U S A; 2015 Nov; 112(46):14366-71. PubMed ID: 26460023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ebola Virus Disease Complicated by Late-Onset Encephalitis and Polyarthritis, Sierra Leone.
    Howlett P; Brown C; Helderman T; Brooks T; Lisk D; Deen G; Solbrig M; Lado M
    Emerg Infect Dis; 2016 Jan; 22(1):150-2. PubMed ID: 26690042
    [No Abstract]   [Full Text] [Related]  

  • 13. Teicoplanin inhibits Ebola pseudovirus infection in cell culture.
    Wang Y; Cui R; Li G; Gao Q; Yuan S; Altmeyer R; Zou G
    Antiviral Res; 2016 Jan; 125():1-7. PubMed ID: 26585243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Good laboratory practices guarantee biosafety in the Sierra Leone-China friendship biosafety laboratory.
    Wang Q; Zhou WM; Zhang Y; Wang HY; Du HJ; Nie K; Song JD; Xiao K; Lei WW; Guo JQ; Wei HJ; Cai K; Wang YH; Wu J; Kamara G; Kamara I; Wei Q; Liang MF; Wu GZ; Dong XP
    Infect Dis Poverty; 2016 Jun; 5(1):62. PubMed ID: 27333890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ebola virus. Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment.
    Sakurai Y; Kolokoltsov AA; Chen CC; Tidwell MW; Bauta WE; Klugbauer N; Grimm C; Wahl-Schott C; Biel M; Davey RA
    Science; 2015 Feb; 347(6225):995-8. PubMed ID: 25722412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ebola hemorrhagic fever: current outbreak and progress in finding a cure.
    Saeidnia S; Abdollahi M
    Daru; 2014 Nov; 22(1):70. PubMed ID: 25392051
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of the FilmArray System for Detection of Zaire ebolavirus in a Small Hospital in Bo, Sierra Leone.
    Leski TA; Ansumana R; Taitt CR; Lamin JM; Bangura U; Lahai J; Mbayo G; Kanneh MB; Bawo B; Bockarie AS; Scullion M; Phillips CL; Horner CP; Jacobsen KH; Stenger DA
    J Clin Microbiol; 2015 Jul; 53(7):2368-70. PubMed ID: 25972415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innovation to confront Ebola in Sierra Leone: the community-care-centre model.
    Michaels-Strasser S; Rabkin M; Lahuerta M; Harripersaud K; Sutton R; Ahoua LN; Ngalamulume B; Franks J; El-Sadr WM
    Lancet Glob Health; 2015 Jul; 3(7):e361-2. PubMed ID: 26087982
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification of entry inhibitors of Ebola virus pseudotyped vectors from a myxobacterial compound library.
    Beck S; Henß L; Weidner T; Herrmann J; Müller R; Chao YK; Grimm C; Weber C; Sliva K; Schnierle BS
    Antiviral Res; 2016 Aug; 132():85-91. PubMed ID: 27241689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ebola Virus Entry: From Molecular Characterization to Drug Discovery.
    Salata C; Calistri A; Alvisi G; Celestino M; Parolin C; Palù G
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30893774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.